The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti-inflammatory Agents Market Research Report 2025
Synopsis
Anti-inflammatory agents block certain substances in the body that cause inflammation. They are used to treat many different conditions such as treat migraines, headaches, rheumatic arthritis, sprains, and menstrual pain. Furthermore, some anti-inflammatory agents such as celecoxib and ibuprofen are being studied for the prevention and treatment of cancer. In addition, they can provide faster relief as compared to other drugs. They are capable of lowering the levels of prostaglandins and the chemicals responsible for inflammation, thereby reducing pain and swelling. Anti-inflammatory drugs usually target the anti-inflammatory mediators or enzymes. These drugs are often used in combination of other drugs. Inflammation is the most prevalent treatable symptom among many immune and respiratory diseases.
The global Anti-inflammatory Agents market was valued at US$ 98100 million in 2023 and is anticipated to reach US$ 129370 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
The growth of the global anti-inflammatory agents market has been driven by factors such as increase in prevalence of autoimmune & respiratory conditions, new drugs in pipeline, and surge in adoption of anti-inflammatory drugs. Furthermore, the demand for anti-inflammatory drugs has been increasing exponentially, owing to the emergence of anti-inflammatory biologics that are more targeted, effective, and with lesser side effects as compared to conventional drugs. Moreover, rise in awareness of anti-inflammatory therapeutics and attractive government initiatives toward the treatment of inflammation with nonsteroidal anti-inflammatory drugs in Asia-Pacific and LAMEA are expected to drive the market growth during the analysis period. However, factors such as side effects of anti-inflammatory drugs and patent expiry issues of blockbuster drugs (such as Remicade) impede the market growth.
This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Agents.
The Anti-inflammatory Agents market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-inflammatory Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-inflammatory Agents companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific Inc
Oracle Corporation
Revvity, Inc
Clario
Illumina, Inc
Qiagen NV
Agilent Technologies, Inc
IBM Corporation
Genedata AG
DNAnexus, Inc
Segment by Type
Software
Services
Segment by Application
Pharmaceutical and Biotechnology Companies
Contract Research and Development Organizations
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-inflammatory Agents company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Anti-inflammatory agents block certain substances in the body that cause inflammation. They are used to treat many different conditions such as treat migraines, headaches, rheumatic arthritis, sprains, and menstrual pain. Furthermore, some anti-inflammatory agents such as celecoxib and ibuprofen are being studied for the prevention and treatment of cancer. In addition, they can provide faster relief as compared to other drugs. They are capable of lowering the levels of prostaglandins and the chemicals responsible for inflammation, thereby reducing pain and swelling. Anti-inflammatory drugs usually target the anti-inflammatory mediators or enzymes. These drugs are often used in combination of other drugs. Inflammation is the most prevalent treatable symptom among many immune and respiratory diseases.
The global Anti-inflammatory Agents market was valued at US$ 98100 million in 2023 and is anticipated to reach US$ 129370 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
The growth of the global anti-inflammatory agents market has been driven by factors such as increase in prevalence of autoimmune & respiratory conditions, new drugs in pipeline, and surge in adoption of anti-inflammatory drugs. Furthermore, the demand for anti-inflammatory drugs has been increasing exponentially, owing to the emergence of anti-inflammatory biologics that are more targeted, effective, and with lesser side effects as compared to conventional drugs. Moreover, rise in awareness of anti-inflammatory therapeutics and attractive government initiatives toward the treatment of inflammation with nonsteroidal anti-inflammatory drugs in Asia-Pacific and LAMEA are expected to drive the market growth during the analysis period. However, factors such as side effects of anti-inflammatory drugs and patent expiry issues of blockbuster drugs (such as Remicade) impede the market growth.
This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Agents.
The Anti-inflammatory Agents market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-inflammatory Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-inflammatory Agents companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific Inc
Oracle Corporation
Revvity, Inc
Clario
Illumina, Inc
Qiagen NV
Agilent Technologies, Inc
IBM Corporation
Genedata AG
DNAnexus, Inc
Segment by Type
Software
Services
Segment by Application
Pharmaceutical and Biotechnology Companies
Contract Research and Development Organizations
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-inflammatory Agents company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-inflammatory Agents Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Software
1.2.3 Services
1.3 Market by Application
1.3.1 Global Anti-inflammatory Agents Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Contract Research and Development Organizations
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-inflammatory Agents Market Perspective (2019-2030)
2.2 Global Anti-inflammatory Agents Growth Trends by Region
2.2.1 Global Anti-inflammatory Agents Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Anti-inflammatory Agents Historic Market Size by Region (2019-2024)
2.2.3 Anti-inflammatory Agents Forecasted Market Size by Region (2025-2030)
2.3 Anti-inflammatory Agents Market Dynamics
2.3.1 Anti-inflammatory Agents Industry Trends
2.3.2 Anti-inflammatory Agents Market Drivers
2.3.3 Anti-inflammatory Agents Market Challenges
2.3.4 Anti-inflammatory Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-inflammatory Agents Players by Revenue
3.1.1 Global Top Anti-inflammatory Agents Players by Revenue (2019-2024)
3.1.2 Global Anti-inflammatory Agents Revenue Market Share by Players (2019-2024)
3.2 Global Anti-inflammatory Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anti-inflammatory Agents Revenue
3.4 Global Anti-inflammatory Agents Market Concentration Ratio
3.4.1 Global Anti-inflammatory Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-inflammatory Agents Revenue in 2023
3.5 Global Key Players of Anti-inflammatory Agents Head office and Area Served
3.6 Global Key Players of Anti-inflammatory Agents, Product and Application
3.7 Global Key Players of Anti-inflammatory Agents, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-inflammatory Agents Breakdown Data by Type
4.1 Global Anti-inflammatory Agents Historic Market Size by Type (2019-2024)
4.2 Global Anti-inflammatory Agents Forecasted Market Size by Type (2025-2030)
5 Anti-inflammatory Agents Breakdown Data by Application
5.1 Global Anti-inflammatory Agents Historic Market Size by Application (2019-2024)
5.2 Global Anti-inflammatory Agents Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Anti-inflammatory Agents Market Size (2019-2030)
6.2 North America Anti-inflammatory Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Anti-inflammatory Agents Market Size by Country (2019-2024)
6.4 North America Anti-inflammatory Agents Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-inflammatory Agents Market Size (2019-2030)
7.2 Europe Anti-inflammatory Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Anti-inflammatory Agents Market Size by Country (2019-2024)
7.4 Europe Anti-inflammatory Agents Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-inflammatory Agents Market Size (2019-2030)
8.2 Asia-Pacific Anti-inflammatory Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Anti-inflammatory Agents Market Size by Region (2019-2024)
8.4 Asia-Pacific Anti-inflammatory Agents Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-inflammatory Agents Market Size (2019-2030)
9.2 Latin America Anti-inflammatory Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Anti-inflammatory Agents Market Size by Country (2019-2024)
9.4 Latin America Anti-inflammatory Agents Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-inflammatory Agents Market Size (2019-2030)
10.2 Middle East & Africa Anti-inflammatory Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Anti-inflammatory Agents Market Size by Country (2019-2024)
10.4 Middle East & Africa Anti-inflammatory Agents Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific Inc
11.1.1 Thermo Fisher Scientific Inc Company Details
11.1.2 Thermo Fisher Scientific Inc Business Overview
11.1.3 Thermo Fisher Scientific Inc Anti-inflammatory Agents Introduction
11.1.4 Thermo Fisher Scientific Inc Revenue in Anti-inflammatory Agents Business (2019-2024)
11.1.5 Thermo Fisher Scientific Inc Recent Development
11.2 Oracle Corporation
11.2.1 Oracle Corporation Company Details
11.2.2 Oracle Corporation Business Overview
11.2.3 Oracle Corporation Anti-inflammatory Agents Introduction
11.2.4 Oracle Corporation Revenue in Anti-inflammatory Agents Business (2019-2024)
11.2.5 Oracle Corporation Recent Development
11.3 Revvity, Inc
11.3.1 Revvity, Inc Company Details
11.3.2 Revvity, Inc Business Overview
11.3.3 Revvity, Inc Anti-inflammatory Agents Introduction
11.3.4 Revvity, Inc Revenue in Anti-inflammatory Agents Business (2019-2024)
11.3.5 Revvity, Inc Recent Development
11.4 Clario
11.4.1 Clario Company Details
11.4.2 Clario Business Overview
11.4.3 Clario Anti-inflammatory Agents Introduction
11.4.4 Clario Revenue in Anti-inflammatory Agents Business (2019-2024)
11.4.5 Clario Recent Development
11.5 Illumina, Inc
11.5.1 Illumina, Inc Company Details
11.5.2 Illumina, Inc Business Overview
11.5.3 Illumina, Inc Anti-inflammatory Agents Introduction
11.5.4 Illumina, Inc Revenue in Anti-inflammatory Agents Business (2019-2024)
11.5.5 Illumina, Inc Recent Development
11.6 Qiagen NV
11.6.1 Qiagen NV Company Details
11.6.2 Qiagen NV Business Overview
11.6.3 Qiagen NV Anti-inflammatory Agents Introduction
11.6.4 Qiagen NV Revenue in Anti-inflammatory Agents Business (2019-2024)
11.6.5 Qiagen NV Recent Development
11.7 Agilent Technologies, Inc
11.7.1 Agilent Technologies, Inc Company Details
11.7.2 Agilent Technologies, Inc Business Overview
11.7.3 Agilent Technologies, Inc Anti-inflammatory Agents Introduction
11.7.4 Agilent Technologies, Inc Revenue in Anti-inflammatory Agents Business (2019-2024)
11.7.5 Agilent Technologies, Inc Recent Development
11.8 IBM Corporation
11.8.1 IBM Corporation Company Details
11.8.2 IBM Corporation Business Overview
11.8.3 IBM Corporation Anti-inflammatory Agents Introduction
11.8.4 IBM Corporation Revenue in Anti-inflammatory Agents Business (2019-2024)
11.8.5 IBM Corporation Recent Development
11.9 Genedata AG
11.9.1 Genedata AG Company Details
11.9.2 Genedata AG Business Overview
11.9.3 Genedata AG Anti-inflammatory Agents Introduction
11.9.4 Genedata AG Revenue in Anti-inflammatory Agents Business (2019-2024)
11.9.5 Genedata AG Recent Development
11.10 DNAnexus, Inc
11.10.1 DNAnexus, Inc Company Details
11.10.2 DNAnexus, Inc Business Overview
11.10.3 DNAnexus, Inc Anti-inflammatory Agents Introduction
11.10.4 DNAnexus, Inc Revenue in Anti-inflammatory Agents Business (2019-2024)
11.10.5 DNAnexus, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Anti-inflammatory Agents Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Software
Table 3. Key Players of Services
Table 4. Global Anti-inflammatory Agents Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Anti-inflammatory Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Anti-inflammatory Agents Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Anti-inflammatory Agents Market Share by Region (2019-2024)
Table 8. Global Anti-inflammatory Agents Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Anti-inflammatory Agents Market Share by Region (2025-2030)
Table 10. Anti-inflammatory Agents Market Trends
Table 11. Anti-inflammatory Agents Market Drivers
Table 12. Anti-inflammatory Agents Market Challenges
Table 13. Anti-inflammatory Agents Market Restraints
Table 14. Global Anti-inflammatory Agents Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Anti-inflammatory Agents Market Share by Players (2019-2024)
Table 16. Global Top Anti-inflammatory Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Agents as of 2023)
Table 17. Ranking of Global Top Anti-inflammatory Agents Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Anti-inflammatory Agents Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Anti-inflammatory Agents, Headquarters and Area Served
Table 20. Global Key Players of Anti-inflammatory Agents, Product and Application
Table 21. Global Key Players of Anti-inflammatory Agents, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-inflammatory Agents Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Anti-inflammatory Agents Revenue Market Share by Type (2019-2024)
Table 25. Global Anti-inflammatory Agents Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Anti-inflammatory Agents Revenue Market Share by Type (2025-2030)
Table 27. Global Anti-inflammatory Agents Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Anti-inflammatory Agents Revenue Market Share by Application (2019-2024)
Table 29. Global Anti-inflammatory Agents Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Anti-inflammatory Agents Revenue Market Share by Application (2025-2030)
Table 31. North America Anti-inflammatory Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Anti-inflammatory Agents Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Anti-inflammatory Agents Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Anti-inflammatory Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Anti-inflammatory Agents Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Anti-inflammatory Agents Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Anti-inflammatory Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Anti-inflammatory Agents Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Anti-inflammatory Agents Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti-inflammatory Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Anti-inflammatory Agents Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Anti-inflammatory Agents Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Anti-inflammatory Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Anti-inflammatory Agents Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Anti-inflammatory Agents Market Size by Country (2025-2030) & (US$ Million)
Table 46. Thermo Fisher Scientific Inc Company Details
Table 47. Thermo Fisher Scientific Inc Business Overview
Table 48. Thermo Fisher Scientific Inc Anti-inflammatory Agents Product
Table 49. Thermo Fisher Scientific Inc Revenue in Anti-inflammatory Agents Business (2019-2024) & (US$ Million)
Table 50. Thermo Fisher Scientific Inc Recent Development
Table 51. Oracle Corporation Company Details
Table 52. Oracle Corporation Business Overview
Table 53. Oracle Corporation Anti-inflammatory Agents Product
Table 54. Oracle Corporation Revenue in Anti-inflammatory Agents Business (2019-2024) & (US$ Million)
Table 55. Oracle Corporation Recent Development
Table 56. Revvity, Inc Company Details
Table 57. Revvity, Inc Business Overview
Table 58. Revvity, Inc Anti-inflammatory Agents Product
Table 59. Revvity, Inc Revenue in Anti-inflammatory Agents Business (2019-2024) & (US$ Million)
Table 60. Revvity, Inc Recent Development
Table 61. Clario Company Details
Table 62. Clario Business Overview
Table 63. Clario Anti-inflammatory Agents Product
Table 64. Clario Revenue in Anti-inflammatory Agents Business (2019-2024) & (US$ Million)
Table 65. Clario Recent Development
Table 66. Illumina, Inc Company Details
Table 67. Illumina, Inc Business Overview
Table 68. Illumina, Inc Anti-inflammatory Agents Product
Table 69. Illumina, Inc Revenue in Anti-inflammatory Agents Business (2019-2024) & (US$ Million)
Table 70. Illumina, Inc Recent Development
Table 71. Qiagen NV Company Details
Table 72. Qiagen NV Business Overview
Table 73. Qiagen NV Anti-inflammatory Agents Product
Table 74. Qiagen NV Revenue in Anti-inflammatory Agents Business (2019-2024) & (US$ Million)
Table 75. Qiagen NV Recent Development
Table 76. Agilent Technologies, Inc Company Details
Table 77. Agilent Technologies, Inc Business Overview
Table 78. Agilent Technologies, Inc Anti-inflammatory Agents Product
Table 79. Agilent Technologies, Inc Revenue in Anti-inflammatory Agents Business (2019-2024) & (US$ Million)
Table 80. Agilent Technologies, Inc Recent Development
Table 81. IBM Corporation Company Details
Table 82. IBM Corporation Business Overview
Table 83. IBM Corporation Anti-inflammatory Agents Product
Table 84. IBM Corporation Revenue in Anti-inflammatory Agents Business (2019-2024) & (US$ Million)
Table 85. IBM Corporation Recent Development
Table 86. Genedata AG Company Details
Table 87. Genedata AG Business Overview
Table 88. Genedata AG Anti-inflammatory Agents Product
Table 89. Genedata AG Revenue in Anti-inflammatory Agents Business (2019-2024) & (US$ Million)
Table 90. Genedata AG Recent Development
Table 91. DNAnexus, Inc Company Details
Table 92. DNAnexus, Inc Business Overview
Table 93. DNAnexus, Inc Anti-inflammatory Agents Product
Table 94. DNAnexus, Inc Revenue in Anti-inflammatory Agents Business (2019-2024) & (US$ Million)
Table 95. DNAnexus, Inc Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Anti-inflammatory Agents Picture
Figure 2. Global Anti-inflammatory Agents Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Anti-inflammatory Agents Market Share by Type: 2023 VS 2030
Figure 4. Software Features
Figure 5. Services Features
Figure 6. Global Anti-inflammatory Agents Market Size by Application (2024-2030) & (US$ Million)
Figure 7. Global Anti-inflammatory Agents Market Share by Application: 2023 VS 2030
Figure 8. Pharmaceutical and Biotechnology Companies Case Studies
Figure 9. Contract Research and Development Organizations Case Studies
Figure 10. Others Case Studies
Figure 11. Anti-inflammatory Agents Report Years Considered
Figure 12. Global Anti-inflammatory Agents Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Anti-inflammatory Agents Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Anti-inflammatory Agents Market Share by Region: 2023 VS 2030
Figure 15. Global Anti-inflammatory Agents Market Share by Players in 2023
Figure 16. Global Top Anti-inflammatory Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Agents as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Anti-inflammatory Agents Revenue in 2023
Figure 18. North America Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Anti-inflammatory Agents Market Share by Country (2019-2030)
Figure 20. United States Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Anti-inflammatory Agents Market Share by Country (2019-2030)
Figure 24. Germany Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Anti-inflammatory Agents Market Share by Region (2019-2030)
Figure 32. China Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Anti-inflammatory Agents Market Share by Country (2019-2030)
Figure 40. Mexico Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Anti-inflammatory Agents Market Share by Country (2019-2030)
Figure 44. Turkey Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. UAE Anti-inflammatory Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Thermo Fisher Scientific Inc Revenue Growth Rate in Anti-inflammatory Agents Business (2019-2024)
Figure 48. Oracle Corporation Revenue Growth Rate in Anti-inflammatory Agents Business (2019-2024)
Figure 49. Revvity, Inc Revenue Growth Rate in Anti-inflammatory Agents Business (2019-2024)
Figure 50. Clario Revenue Growth Rate in Anti-inflammatory Agents Business (2019-2024)
Figure 51. Illumina, Inc Revenue Growth Rate in Anti-inflammatory Agents Business (2019-2024)
Figure 52. Qiagen NV Revenue Growth Rate in Anti-inflammatory Agents Business (2019-2024)
Figure 53. Agilent Technologies, Inc Revenue Growth Rate in Anti-inflammatory Agents Business (2019-2024)
Figure 54. IBM Corporation Revenue Growth Rate in Anti-inflammatory Agents Business (2019-2024)
Figure 55. Genedata AG Revenue Growth Rate in Anti-inflammatory Agents Business (2019-2024)
Figure 56. DNAnexus, Inc Revenue Growth Rate in Anti-inflammatory Agents Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
